Regents of the University of California’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-135,273
Closed -$11M 31
2020
Q2
$11M Sell
135,273
-26,889
-17% -$2.17M 1.54% 5
2020
Q1
$11.3M Buy
162,162
+84,666
+109% +$6.5M 1.68% 5
2019
Q4
$6.06M Sell
77,496
-1,910
-2% -$138K 3.19% 4
2019
Q3
$5.07M Buy
+79,406
New +$7M 9.7% 3

Other funds holding GH

Regents of the University of California's GH Position: Q3 2020 in Review

Regents of the University of California sold out of Guardant Health (GH) in Q3 2020, closing a stake of 135,273 shares — an estimated $11M sold.

Regents of the University of California first reported a position in GH in Q3 2019 and held it in 4 quarters. The position peaked at $11.3M in Q1 2020. 346 funds tracked by Wall St. Rank hold GH as of Q3 2020.

  • Regents of the University of California reported no remaining Guardant Health position as of Q3 2020 after selling out during the quarter.
  • Regents of the University of California sold 135,273 Guardant Health shares in Q3 2020, an estimated $11M.
  • Regents of the University of California first reported a position in Guardant Health in Q3 2019 and held it in 4 quarters.
  • Regents of the University of California's Guardant Health position peaked at $11.3M in Q1 2020.
  • 346 funds tracked by Wall St. Rank held Guardant Health as of Q3 2020.

Based on Regents of the University of California's 13F filing for Q3 2020, filed 21 Oct 2020.